Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38401 - 38425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	RUNDC3A	10900	downregulated	entinostat results in decreased expression of RUNDC3A mRNA	17q21.31	A21035
Entinostat	Investigational	RUNX1T1	862	upregulated	entinostat results in increased expression of RUNX1T1 mRNA	8q21.3	A21037
Entinostat	Investigational	RUNX3	864	upregulated	entinostat results in increased expression of RUNX3 mRNA	1p36.11	A21037 A21035
Entinostat	Investigational	RUSC1-AS1	284618	downregulated	entinostat results in decreased expression of RUSC1-AS1 mRNA	1q22	A21035
Entinostat	Investigational	RYR3	6263	downregulated	entinostat results in decreased expression of RYR3 mRNA	15q13.3-q14	A21037
Entinostat	Investigational	S100A10	6281	upregulated	entinostat results in increased expression of S100A10 mRNA	1q21.3	A21037
Entinostat	Investigational	S100A13	6284	upregulated	entinostat results in increased expression of S100A13 mRNA	1q21.3	A21035
Entinostat	Investigational	S100A2	6273	upregulated	entinostat results in increased expression of S100A2 mRNA	1q21.3	A21035
Entinostat	Investigational	S100A4	6275	upregulated	entinostat results in increased expression of S100A4 mRNA	1q21.3	A21037 A21035
Entinostat	Investigational	S100A6	6277	upregulated	entinostat results in increased expression of S100A6 mRNA	1q21.3	A21037 A21035
Entinostat	Investigational	S100B	6285	upregulated	entinostat results in increased expression of S100B mRNA	21q22.3	A21035
Entinostat	Investigational	S100P	6286	upregulated	entinostat results in increased expression of S100P mRNA	4p16.1	A21035
Entinostat	Investigational	S1PR1	1901	upregulated	entinostat results in increased expression of S1PR1 mRNA	1p21.2	A21035
Entinostat	Investigational	S1PR3	1903	downregulated	entinostat results in decreased expression of S1PR3 mRNA	9q22.1	A21037
Entinostat	Investigational	S1PR5	53637	upregulated	entinostat results in increased expression of S1PR5 mRNA	19p13.2	A21037 A21035
Entinostat	Investigational	SALL3	27164	downregulated	entinostat results in decreased expression of SALL3 mRNA	18q23	A21037
Entinostat	Investigational	SAMHD1	25939	upregulated	entinostat results in increased expression of SAMHD1 mRNA	20q11.23	A21037 A21035
Entinostat	Investigational	SAP30L-AS1	386627	upregulated	entinostat results in increased expression of SAP30L-AS1 mRNA	5q33.2	A21035
Entinostat	Investigational	SATB1	6304	downregulated	entinostat results in decreased expression of SATB1 mRNA	3p24.3	A21037
Entinostat	Investigational	SBF2	81846	upregulated	entinostat results in increased expression of SBF2 mRNA	11p15.4	A21037
Entinostat	Investigational	SBSPON	157869	upregulated	entinostat results in increased expression of SBSPON mRNA	8q21.11	A21035
Entinostat	Investigational	SC5D	6309	upregulated	entinostat results in increased expression of SC5D mRNA	11q23.3-q24.1	A21037
Entinostat	Investigational	SCAPER	49855	downregulated	entinostat results in decreased expression of SCAPER mRNA	15q24.3	A21037
Entinostat	Investigational	SCARA3	51435	upregulated	entinostat results in increased expression of SCARA3 mRNA	8p21.1	A21035
Entinostat	Investigational	SCARB1	949	upregulated	entinostat results in increased expression of SCARB1 mRNA	12q24.31	A21037

Displaying entries 38401 - 38425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability